Abstract:BACKGROUND For the clinical care of patients with well-established diseases, randomized trials, literature, and research are supplemented with clinical judgment to understand disease prognosis and inform treatment choices. In the void created by a lack of clinical experience with COVID-19, artificial intelligence (AI) may be an important tool to bolster clinical judgment and decision making. However, a lack of clinical data restricts the design and development of such AI tools, particularly in preparation for an impending crisis or pandemic. OBJECTIVE This study aimed to develop and test the feasibility of a “patients-like-me” framework to predict the deterioration of patients with COVID-19 using a retrospective cohort of patients with similar respiratory diseases. METHODS Our framework used COVID-19–like cohorts to design and train AI models that were then validated on the COVID-19 population. The COVID-19–like cohorts included patients diagnosed with bacterial pneumonia, viral pneumonia, unspecified pneumonia, influenza, and acute respiratory distress syndrome (ARDS) at an academic medical center from 2008 to 2019. In total, 15 training cohorts were created using different combinations of the COVID-19–like cohorts with the ARDS cohort for exploratory purposes. In this study, two machine learning models were developed: one to predict invasive mechanical ventilation (IMV) within 48 hours for each hospitalized day, and one to predict all-cause mortality at the time of admission. Model performance was assessed using the area under the receiver operating characteristic curve (AUROC), sensitivity, specificity, positive predictive value, and negative predictive value. We established model interpretability by calculating SHapley Additive exPlanations (SHAP) scores to identify important features. RESULTS Compared to the COVID-19–like cohorts (n=16,509), the patients hospitalized with COVID-19 (n=159) were significantly younger, with a higher proportion of patients of Hispanic ethnicity, a lower proportion of patients with smoking history, and fewer patients with comorbidities ( P <.001). Patients with COVID-19 had a lower IMV rate (15.1 versus 23.2, P =.02) and shorter time to IMV (2.9 versus 4.1 days, P <.001) compared to the COVID-19–like patients. In the COVID-19–like training data, the top models achieved excellent performance (AUROC>0.90). Validating in the COVID-19 cohort, the top-performing model for predicting IMV was the XGBoost model (AUROC=0.826) trained on the viral pneumonia cohort. Similarly, the XGBoost model trained on all 4 COVID-19–like cohorts without ARDS achieved the best performance (AUROC=0.928) in predicting mortality. Important predictors included demographic information (age), vital signs (oxygen saturation), and laboratory values (white blood cell count, cardiac troponin, albumin, etc). Our models had class imbalance, which resulted in high negative predictive values and low positive predictive values. CONCLUSIONS We provided a feasible framework for modeling patient deterioration using existing data and AI technology to address data limitations during the onset of a novel, rapidly changing pandemic.

GACEMV: An ensemble learning framework for constructing COVID-19 diagnosis and prognosis models

A Prediction Model Based on Machine Learning for Diagnosing the Early COVID-19 Patients

An Explainable AI Approach for the Rapid Diagnosis of COVID-19 Using Ensemble Learning Algorithms

An innovative ensemble model based on deep learning for predicting COVID-19 infection

An Ensemble Prediction Model for COVID-19 Mortality Risk

An Adaptive Combined Learning of Grading System for Early Stage Emerging Diseases

Differential Evolution Optimization Based Ensemble Framework for Accurate Cervical Cancer Diagnosis

GCAEMDA: Predicting Mirna-Disease Associations Via Graph Convolutional Autoencoder

COVID-19 Mortality Prediction Using Ensemble Learning and Grey Wolf Optimization.

Computer-Aided System for COVID-19 Using Semi-supervised-based Ensemble Learning and Reinforcement Learning

Learning From Past Respiratory Infections to Predict COVID-19 Outcomes: Retrospective Study

Reinforcement Learning based Diagnosis and Prediction for COVID-19 from CT Images

Deep Ensemble Model for COVID-19 Diagnosis and Classification Using Chest CT Images

Learning From Past Respiratory Infections to Predict COVID-19 Outcomes: Retrospective Study (Preprint)

Interpretable Machine Learning for COVID-19: An Empirical Study on Severity Prediction Task

Prediction of Covid-19 Multiparametric Biomarkers and Drug Target of Patients for Risk Stratification Using Machine Learning Approach

An interpretable machine learning framework for diagnosis and prognosis of COVID-19

CovidCare: Transferring Knowledge from Existing EMR to Emerging Epidemic for Interpretable Prognosis

Reinforcement Learning Based Diagnosis and Prediction for COVID-19 by Optimizing a Mixed Cost Function From CT Images

EACVP: An ESM-2 LM Framework Combined CNN and CBAM Attention to Predict Anti-coronavirus Peptides